These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7697342)

  • 61. Complex structure and regulation of the P16 (MTS1) locus.
    Stone S; Jiang P; Dayananth P; Tavtigian SV; Katcher H; Parry D; Peters G; Kamb A
    Cancer Res; 1995 Jul; 55(14):2988-94. PubMed ID: 7606716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma.
    Miller CW; Yeon C; Aslo A; Mendoza S; Aytac U; Koeffler HP
    Oncogene; 1997 Jul; 15(2):231-5. PubMed ID: 9244358
    [TBL] [Abstract][Full Text] [Related]  

  • 63. p16INK4A as a human tumor suppressor.
    Shapiro GI; Rollins BJ
    Biochim Biophys Acta; 1996 Mar; 1242(3):165-9. PubMed ID: 8603068
    [No Abstract]   [Full Text] [Related]  

  • 64. Deletion and differential expression of p16INK4a in mouse lung tumors.
    Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J
    Carcinogenesis; 1997 Jan; 18(1):115-20. PubMed ID: 9054597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alteration of p16 and p15 genes in common epithelial ovarian tumors.
    Fujita M; Enomoto T; Haba T; Nakashima R; Sasaki M; Yoshino K; Wada H; Buzard GS; Matsuzaki N; Wakasa K; Murata Y
    Int J Cancer; 1997 Apr; 74(2):148-55. PubMed ID: 9133447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
    Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Absence of p18 mutations or deletions in lymphoid malignancies.
    Otsuki T; Jaffe ES; Wellmann A; Kumar S; Condron KS; Raffeld M
    Leukemia; 1996 Feb; 10(2):356-60. PubMed ID: 8637248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas.
    Tenan M; Benedetti S; Finocchiaro G
    Biochem Biophys Res Commun; 1995 Dec; 217(1):195-202. PubMed ID: 8526910
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
    Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
    Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
    Tahara H; Smith AP; Gaz RD; Arnold A
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
    Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
    Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
    Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyclin-dependent kinase inhibitors and human cancer.
    Kamb A
    Curr Top Microbiol Immunol; 1998; 227():139-48. PubMed ID: 9479829
    [No Abstract]   [Full Text] [Related]  

  • 76. [Treatment of arthritis with cyclin-dependent kinase inhibitor p 16INK4a gene].
    Kohsaka H; Taniguchi K; Nonomura Y; Nagasaka K; Inoue N; Nasu K; Miyasaka N
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):397-9. PubMed ID: 10726472
    [No Abstract]   [Full Text] [Related]  

  • 77. [BS69 and RACK7, a potential novel class of tumor suppressor genes].
    Ansieau S; Sergeant A
    Pathol Biol (Paris); 2003 Sep; 51(7):397-9. PubMed ID: 12948759
    [No Abstract]   [Full Text] [Related]  

  • 78. Tumor suppressor genes.
    Weinberg R
    Neuron; 1993 Aug; 11(2):191-6. PubMed ID: 8352939
    [No Abstract]   [Full Text] [Related]  

  • 79. Inhibition of cyclin D1 expression and induction of apoptosis by inostamycin in small cell lung carcinoma cells.
    Imoto M; Tanabe K; Simizu S; Tashiro E; Takada M; Umezawa K
    Jpn J Cancer Res; 1998 Mar; 89(3):315-22. PubMed ID: 9600126
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.
    Marchini S; Codegoni AM; Bonazzi C; Chiari S; Broggini M
    Br J Cancer; 1997; 76(2):146-9. PubMed ID: 9231912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.